Asked by: Olivia Blake (Labour - Sheffield Hallam)
Question to the Ministry of Housing, Communities and Local Government:
To ask the Secretary of State for Housing, Communities and Local Government, what steps he is taking to ensure that the upcoming Homelessness Strategy addresses homelessness among newly recognised refugees arising from the 28 day move-on period.
Answered by Alison McGovern - Minister of State (Housing, Communities and Local Government)
Through A National Plan to End Homelessness, the Cross-Government Homelessness and Rough Sleeping Strategy, the Home Office has committed to strengthen data sharing processes to ensure councils receive information from asylum accommodation providers for 100% of newly granted refugees at risk of homelessness, within two days of an asylum discontinuation of support notification. This supports early intervention by enabling councils to commence homelessness assessments.
Asked by: Olivia Blake (Labour - Sheffield Hallam)
Question to the Home Office:
To ask the Secretary of State for the Home Department, with reference to Restoring Control Over the Immigration System: White Paper, whether her Department plans to apply the 5 and 10 year penalties for accessing public funds to those on limited leave to remain who are currently living in the UK and receiving benefits.
Answered by Mike Tapp - Parliamentary Under-Secretary (Home Office)
Data regarding how many people in the UK are subject to the ‘no recourse to public funds’ condition (NRPF) is currently in development and not ready for release. We will continue to explore what further information on NRPF can be produced. We are unable at this time to provide a specific timeframe for data publication or indeed confirm what will be published.
The earned settlement model is currently subject to a public consultation, running until 12 February 2026. Details of the earned settlement scheme will be finalised following that consultation.
The consultation seeks views on whether there should be transitional arrangements for those already on a pathway to settlement. Consideration will then be given, if appropriate, to how transitional arrangements may be designed to ease the impact of policy change, especially for individuals or groups already afforded permissions by the previous system.
The final model will also be subject to equality impact assessment, which the government has committed to publish in due course.
Free school meals are not classed as a 'public fund' for immigration purposes. It is the Department for Education who set the eligibility criteria for who can access free school meals.
Asked by: Olivia Blake (Labour - Sheffield Hallam)
Question to the Home Office:
To ask the Secretary of State for the Home Department, how many (a) children and (b) adults are subject to the No Recourse to Public Funds condition.
Answered by Mike Tapp - Parliamentary Under-Secretary (Home Office)
Data regarding how many people in the UK are subject to the ‘no recourse to public funds’ condition (NRPF) is currently in development and not ready for release. We will continue to explore what further information on NRPF can be produced. We are unable at this time to provide a specific timeframe for data publication or indeed confirm what will be published.
The earned settlement model is currently subject to a public consultation, running until 12 February 2026. Details of the earned settlement scheme will be finalised following that consultation.
The consultation seeks views on whether there should be transitional arrangements for those already on a pathway to settlement. Consideration will then be given, if appropriate, to how transitional arrangements may be designed to ease the impact of policy change, especially for individuals or groups already afforded permissions by the previous system.
The final model will also be subject to equality impact assessment, which the government has committed to publish in due course.
Free school meals are not classed as a 'public fund' for immigration purposes. It is the Department for Education who set the eligibility criteria for who can access free school meals.
Asked by: Olivia Blake (Labour - Sheffield Hallam)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the Cancer Plan will specifically address the availability of products containing Melanotan II.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is taking steps to prevent, diagnose, and treat cancers more quickly, including skin cancers. The forthcoming National Cancer Plan will cover the entirety of the cancer pathway from referral and diagnosis to treatment and ongoing care. It will set out how we will improve outcomes for cancer patients, including by speeding up diagnosis and treatment, ensuring patients have access to the latest treatments and technology, and ultimately driving up this country’s cancer survival rates. We will publish the National Cancer Plan in the new year to reduce the number of lives lost to cancer over the next 10 years.
We received over 11,000 responses to our call for evidence from individuals, professionals, and organisations, and we are reviewing the submissions from skin cancer partners. While no formal assessment has been made of the availability and levels of the use of tan-enhancing products containing Melanotan II, respondents shared concerns about tanning products and their potential links to cancer, particularly melanoma. Our expansive engagement will allow the National Cancer Plan to have patients at its heart.
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for the regulation of medicinal products and medical devices in the United Kingdom.
Although tanning is not considered to be a medical purpose, injectable products containing Melanotan I or Melanotan II have been determined as medicinal products due to their similarity to the authorised medicine Scenesse.
In relation to nasal sprays containing Melanotan I or Melanotan II, there are no equivalent authorised medicines, and in the absence of medicinal claims, they are not regarded as medicinal products.
Medicinal products must hold a relevant Marketing Authorisation to be legally sold and supplied in the United Kingdom. This also guarantees that the medicines have been tested for conformity with strict standards of quality, safety, and efficacy. The MHRA takes action when a medicinal product without appropriate authorisations is identified.
Asked by: Olivia Blake (Labour - Sheffield Hallam)
Question to the Home Office:
To ask the Secretary of State for the Home Department, which government departments and schemes will explicitly include families with No Recourse to Public Funds (NRPF) within their eligibility criteria following the introduction of new guidance; and what steps will be taken to monitor and enforce consistency of support across these schemes.
Answered by Mike Tapp - Parliamentary Under-Secretary (Home Office)
The new guidance being produced by the Home Office is designed to assist local authorities in supporting families with NRPF, as set out in the Child Poverty Strategy. The guidance will provide clarity around statutory duties and key safeguards for local authorities, ensuring a clear and consistent approach. The guidance does not alter the eligibility criteria for any current schemes or benefits.
Children whose families are subject to the ‘no recourse to public funds’ condition (NRPF) can currently access schemes and benefits such as free school meals, 15 hours of free childcare for disadvantaged two-year-olds and15 hours free childcare for three- to four-year-old.
The Home Office will continue to work across government where relevant to ensure that migrant children with NRPF are specifically considered when reviewing or deciding on eligibility for schemes and benefits.
Asked by: Olivia Blake (Labour - Sheffield Hallam)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, who has responsibility for preventing the availability of products containing Melanotan II in England; and what steps he has taken to tackle the availability of these products.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Medicines and Healthcare products Regulatory Agency (MHRA) is required to determine whether products are medicines on a case-by-case basis taking into account the definition of a medicine in The Human Medicines Regulations 2012, relevant case law, and any other evidence.
Melanotan II injections and pens are considered medicinal products due to their similarity to an authorised medicinal product and potential application to other medical conditions.
However, tan-enhancing nasal products which are clearly marketed for self-tanning purposes and which do not have a medical purpose do not fall under medicines regulations and are not within the MHRA’s remit.
Medicinal products must hold a relevant Marketing Authorisation to be legally sold and supplied in the United Kingdom. This also guarantees that the medicines have been tested for conformity with strict standards of quality, safety, and efficacy.
Asked by: Olivia Blake (Labour - Sheffield Hallam)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, to set out the legal status of products containing Melanotan II, including i) tan-enhancing injections; ii) tan-enhancing nasal sprays; iii) other products the Department is aware of.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Medicines and Healthcare products Regulatory Agency (MHRA) is required to determine whether products are medicines on a case-by-case basis, taking into account the definition of a medicine in the Human Medicines Regulations 2012, relevant case law, and any other evidence.
There are many products which modify physiological function but which are not medicinal products, and case law has established that products that do so while having no beneficial effects on human health cannot be medicines.
Melanotan II injections and pens are considered medicinal products due to their similarity to an authorised medicinal product and potential application to other medical conditions.
However, tan-enhancing nasal products which are clearly marketed for self-tanning purposes and which do not have a medical purpose do not fall under medicines regulations and are not within the MHRA’s remit.
Asked by: Olivia Blake (Labour - Sheffield Hallam)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will consider introducing a more centralised process for Freedom of Information requests concerning surgeons across England.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
A Freedom of Information (FOI) request is a request for recorded information held by that public authority. The Department is only able to respond to requests for information that it holds at the time of the request, and interaction with other public authorities on FOIs is therefore limited. All requests must be handled in line with the principles of the FOI Act and the guidance issued by the Information Commissioner's Office, as the FOI regulator. There is therefore no ability at present for the Department to operate a separate process for any specific topics or areas of interest.
Asked by: Olivia Blake (Labour - Sheffield Hallam)
Question to the Department for Transport:
To ask the Secretary of State for Transport, what steps she has taken to increase the number of lamppost chargers for electric vehicles.
Answered by Keir Mather - Parliamentary Under-Secretary (Department for Transport)
The Government’s £400 million Local Electric Vehicle Infrastructure (LEVI) Fund has been allocated to all highest tier local authorities in England to ensure equitable chargepoint rollout across the country. Funding is primarily targeted at low powered, on-street charging infrastructure such as lamp column chargepoints to make it easier and more convenient for residents without off-street parking, such as those in terraced housing, to charge close to home.
The Government has also allocated £25 million to English local authorities to install pavement channels, which will support thousands of residents without off-street parking to conveniently charge their vehicles at home, accessing cheaper tariffs through their domestic energy supplies.
Asked by: Olivia Blake (Labour - Sheffield Hallam)
Question to the Department for Transport:
To ask the Secretary of State for Transport, what steps her Department is taking make it easier for those in terraced houses to charge their electric vehicle by their home.
Answered by Keir Mather - Parliamentary Under-Secretary (Department for Transport)
The Government’s £400 million Local Electric Vehicle Infrastructure (LEVI) Fund has been allocated to all highest tier local authorities in England to ensure equitable chargepoint rollout across the country. Funding is primarily targeted at low powered, on-street charging infrastructure such as lamp column chargepoints to make it easier and more convenient for residents without off-street parking, such as those in terraced housing, to charge close to home.
The Government has also allocated £25 million to English local authorities to install pavement channels, which will support thousands of residents without off-street parking to conveniently charge their vehicles at home, accessing cheaper tariffs through their domestic energy supplies.